Credits: Canva
The clothes you wear when you work out may do you more harm than helping you to stay healthy as you hit the gym. This is because research has revealed alarming levels of bisphenol A (BPA), a chemical compound linked to significant health risks in several sports wear, including sports bra, leggings, and athletic wear. The Center for Environmental Health (CEH), which is a nonprofit consumer advocacy group has brought these concerns to light, and have raised awareness about the potential danger and damage these sports wear can cause because of the common chemicals used.
Bisphenol A, or BPA is a chemical that is used to make plastics and resins. It is also used in certain fabrics and is known for its endocrine-disrupting properties, which can also interfere with one's hormonal balance. There have been studies, including a 2019 study titled The adverse health effects of bisphenol A and related toxicity mechanisms that have linked BPA exposure to various health problems, including asthma, cardiovascular diseases, obesity, diabetes, and even cancer.
Many of research which have been conducted focus on the ingestion, which can happen when you store food in BPA-lined containers. Among them, some of the more recent studies show that skin absorption is also a pathway. This means when you are handling receipts which are printed on thermal paper, or wear BPA-containing fabrics, the chemical can seep through your skin and enter your bloodstream.
Though it is also true that BPA is exposed from the body within days, however, continuous exposure from multiple sources can be concerning.
CEH also tested popular athletic wear in October 2023 and found BPA levels were exceeding California's safety standards by as much as 22 times.
Testing also showed that top brands contained up to 40 times the permissible limit of BPA.
As far as laws are concerned, under California's Proposition 65, the maximum allowable dose for BPA exposure via skin is 3 micrograms per day. While this law is among the strictest in the United States, it highlights a broader issue of chemical safety in consumer products nationwide.
Ana Soto, an immunologist with decades of research on BPA, even low doses of dermal and oral exposure can combine to create a significant health risk. She also warned that prolonged exposure through fabric, especially when you are exercising, as your pores are open and sweat is present, can in fact, amplify these effects.
BPA can disrupt your body's endocrine system, which is a network of glands and organs that produce hormones that control many bodily functions. These include growth and development, metabolism, and reproduction, to name a few. BPA can mimic natural hormones like estrogen and interfere in those bodily functions.
Studies also link it with obesity and diabetes, respiratory issues, especially asthma risk in school-aged children, cardiovascular diseases, and cancer risks.
There are certain steps you can follow to protect yourself:
Credit: AI Generated Image
Keeping your cholesterol levels in a healthy range is one of the best things you can do for your heart. High cholesterol is a major risk factor for heart disease, but the good news is that what you eat can make a significant difference. While some people may need medication, research shows that certain foods can naturally help lower LDL cholesterol and support overall cardiovascular health.
One of the easiest places to start is with oats. Oats are packed with a soluble fiber called beta-glucan, which helps reduce the amount of cholesterol absorbed into your bloodstream. A review published in Nutrients found that regularly eating oat beta-glucan can lead to meaningful reductions in LDL cholesterol, especially when combined with an overall heart-healthy diet.
Legumes such as beans, lentils, and chickpeas are another powerful addition to your plate. They're rich in fiber and plant-based protein, making them an excellent alternative to processed meats and other foods high in saturated fat. Research has consistently linked regular legume consumption with lower LDL cholesterol levels and better heart health.
Nuts also deserve a place in a cholesterol-friendly diet. Almonds, walnuts, and other tree nuts provide healthy unsaturated fats, fiber, and antioxidants. According to studies published in the American Journal of Clinical Nutrition, moderate nut consumption can help improve cholesterol levels and support cardiovascular health.
Fatty fish like salmon, sardines, and mackerel are well known for their heart-protective benefits. These fish are rich in omega-3 fatty acids, which can help lower triglycerides and support healthy blood vessels. The American Heart Association recommends eating fatty fish at least twice a week as part of a balanced diet.
Fruits and vegetables remain some of the most important foods for maintaining healthy cholesterol levels. Apples, berries, oranges, leafy greens, and broccoli provide fiber, vitamins, antioxidants, and plant compounds that help protect the heart. Numerous studies have shown that diets rich in fruits and vegetables are associated with a lower risk of cardiovascular disease.
Also Read: Australia Reports H5 Bird Flu In Second State; Can It Spread to Humans?
Avocados are another heart-smart choice. They contain monounsaturated fats and fiber, both of which can help improve cholesterol levels when used in place of foods high in saturated fat. A clinical study published in the Journal of the American Heart Association found that people who ate one avocado daily experienced greater reductions in LDL cholesterol than those following similar diets without avocado.
The bottom line is that controlling cholesterol doesn't require a drastic diet overhaul. Small, consistent changes—such as eating more whole grains, legumes, nuts, fruits, vegetables, fatty fish, and healthy fats—can have a lasting impact on heart health. Combined with regular exercise and other healthy lifestyle habits, these foods can help keep your cholesterol in check and support long-term well-being.

Credit: AI generated image
Sleep is one of the most important factors for overall health and well-being, influencing both physical and mental health. Yet, how much sleep a person actually needs remains a common topic of debate.
Dr Sudhir Kumar, a neurologist at Apollo Hospitals, addressed several misconceptions and shared evidence-based insights about sleep that everyone should know.
In a detailed post on social media platform X, Dr Sudhir said that most adults need 7–9 hours of sleep per night.
While some may function well with slightly less or more sleep, he noted that "regularly sleeping less than six hours or more than 9–10 hours is associated with adverse health outcomes."
While sleep duration is important, sleep consistency is equally important.
"Going to bed and waking up at roughly the same time every day helps regulate your circadian rhythm," he said.
Irregular sleep schedules, on the other hand, are associated with poorer metabolic health, mood disturbances, and daytime sleepiness.
Also read: Did Donald Trump Take Eli Lilly's Weight Loss Drug? What Did White House Say
Dr Sudhir said that most modern adults follow a monophasic pattern, with one main sleep period at night.
However, "a biphasic pattern (night sleep plus a short afternoon nap) can also be healthy if total sleep duration is adequate and the nap does not interfere with nighttime sleep."
Not necessarily, said Dr Sudhir, popularly known as Hyderabaddoc on X, adding that many healthy adults do perfectly well without naps.
However, naps may be particularly useful for:
• Shift workers
• People with sleep debt
• Older adults with increased daytime sleepiness
• Those performing safety-critical tasks requiring sustained alertness
Further, he said that a 10–30-minute nap, also known as a power nap, is usually best, and may help:
• Improve alertness
• Improve concentration
• Reduce fatigue
• Enhance performance
However, naps lasting more than an hour may cause "sleep inertia" (grogginess) and disrupt nighttime sleep in some individuals.
Read More: 'Omega Block' Causing Europe Heatwave; France Worst Hit
"Night shift work is not biologically normal," Dr Sudhir said.
Humans are programmed to be awake during the day and asleep at night. Long-term night shift work has been associated with increased risks of:
• Obesity
• Type 2 diabetes
• Cardiovascular disease
• Mood disorders
• Workplace accidents
Dr Sudhir also addressed the common belief that people can make up for lost sleep during weekends.
While "partial recovery is possible," he said weekend catch-up sleep does not fully reverse the effects of chronic sleep deprivation.
Large shifts in sleep timing during weekends, often referred to as "social jet lag," can disrupt circadian rhythms.
He advised keeping wake-up and bedtime within about one to two hours of the weekday schedule.
He also warned against relying on multiple alarms every morning, which according to him "suggests insufficient sleep, poor sleep quality, and circadian misalignment."
Dr Sudhir said regularly sleeping more than 9–10 hours may be associated with higher risks of cardiovascular disease, depression, frailty, and mortality.
At the same time, the neurologist noted that "even one night of inadequate sleep can impair performance".
Short-term sleep deprivation can lead to:
• Reduced attention
• Slower reaction time
• Poor decision-making
• Mood changes
• Increased accident risk
Chronic insufficient sleep is associated with:
• Hypertension
• Type 2 diabetes
• Obesity
• Cardiovascular disease
• Depression and anxiety
• Cognitive decline
• Reduced quality of life
"Sleep is a fundamental biological requirement, just like nutrition and exercise," Dr Sudhir said.
Credit: iStock
GLP-1 receptor agonists (GLP-1 RAs), including semaglutide widely used to improve diabetes control and promote weight loss, may also reduce the risk of colorectal cancer, according to a new study.
The study found that the effect was particularly notable among people with inflammatory bowel disease (IBD), as well as those with both IBD and type 2 diabetes. Both conditions are associated with a higher risk of colorectal cancer due to chronic inflammation and metabolic changes that may promote tumor development.
"GLP-1 RA use was associated with a significantly reduced incidence of colorectal cancer in all patients with IBD, as well as the subpopulation with both IBD and type 2 diabetes," said lead author Sarina Ailawadi of Case Western Reserve University, US.
"Given the elevated colorectal cancer risk in IBD, these findings suggest a potential protective effect of GLP-1 RA use in this high-risk population. Prospective studies will be important to further analyze and confirm this potential benefit," she added.
The findings will be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough meeting, scheduled for June 25–27 in Singapore.
Also read: Robert F. Kennedy Jr. Launches Reforms To Speed Up Early Drug Research In US
This retrospective cohort study analyzed data from 69,221 people in the US, including GLP-1 RA users and non-users.
Researchers also identified 209,649 people with both IBD and type 2 diabetes, including 38,567 who had taken a GLP-1 RA.
After matching users and non-users for various characteristics, data from 37,740 patients were analyzed. The GLP-1 RA group included people taking semaglutide, dulaglutide, tirzepatide, exenatide, liraglutide, or lixisenatide.
The researchers compared the five-year incidence of colorectal cancer between GLP-1 RA users and non-users.
Among people with IBD, the five-year incidence of colorectal cancer was 0.2% in GLP-1 RA users compared with 0.42% in non-users. The odds ratio was 0.49, indicating a 51% lower likelihood of developing colorectal cancer among GLP-1 RA users.
Among patients with both IBD and type 2 diabetes, the five-year incidence of colorectal cancer was 0.31% in GLP-1 RA users and 0.57% in non-users. The odds ratio was 0.54, suggesting a 46% lower likelihood of developing colorectal cancer.
The researchers noted that prospective studies are needed to confirm the potential protective effect of GLP-1 RAs on colorectal cancer risk.
Inflammatory bowel disease is associated with a higher risk of colorectal cancer, likely because of chronic inflammation in the intestines. People with IBD are estimated to be six times more likely to develop colorectal cancer than those without the condition.
Type 2 diabetes, the most common form of diabetes, also increases colorectal cancer risk and is becoming more common among people with IBD. Scientists believe that individuals with both conditions may face an especially high risk because of the combined effects of chronic inflammation and metabolic dysfunction.
GLP-1 receptor agonists are a class of drugs that help lower blood sugar levels and promote weight loss. Originally developed to treat type 2 diabetes, many are now widely used for weight management.
These medications mimic the action of the GLP-1 hormone by stimulating insulin release, slowing digestion, and increasing feelings of fullness.
Beyond blood sugar control and weight loss, GLP-1 RAs have been linked to several health benefits, including lower blood pressure and reduced cardiovascular risk. Previous studies have also suggested that they may lower the risk of colorectal cancer and other obesity-related cancers.
However, their specific impact on colorectal cancer risk among people with IBD has remained unclear until now.
© 2024 Bennett, Coleman & Company Limited